By Josh Beckerman
OncoSec Medical Inc. shares were down 18% to $2.16 after the company said it plans to offer 11.66 million shares and 11.66 million warrants.
The cancer-focused biotechnology company said certain investors may buy pre-funded warrants instead of shares due to potential ownership limits.
OncoSec shares fell 24% on Feb. 2 after it announced a stock and warrant offering and rose 89% on March 1 after it withdrew the offering.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
March 28, 2023 14:50 ET (18:50 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.